AC Immune to Present Progress of Alzheimer's Disease Program

AC Immune to Present Progress of Alzheimer’s Disease Programs targeting Abeta and Tau at the 15th CTAD Conference Next generation SupraAntigen® liposomal vaccine platform augments immunization against pathological targets of Alzheimer’s diseaseNew data on anti-phospho-Tau vaccines confirm safety...

Related Keywords

Stanford , California , United States , Switzerland , San Francisco , Gary Waanders , Marie Kosco Vilbois , Eli Lilly , Christina Young , Johannes Streffer , Andrea Pfeifer , Genentech Roche , Stephen Schauer , Ericm Reiman , Head Of Investor Relations Corporate Communications , Genentech , Janssen Pharmaceuticals , Janssen Pharmaceuticals Inc , Roche Group , Banner Alzheimer Institute , Present Progress , Disease Programs , Clinical Trials , Chief Medical Officer , Chief Scientific Officer , Life Molecular Imaging , Interim Phase , Biomarker Findings , Disease Colombia , Banner Alzheimer , Mild To Moderate Alzheimer , Investor Relations ,